From epidemiology to molecular pathology: current research status and future prospects on the role of toxic metal exposure in the development and progression of bladder cancer
Bladder cancer remains a prevalent and lethal urinary malignancy, characterized by high recurrence rates and persistently poor prognosis for muscle-invasive disease. This clinical reality underscores the urgent need to identify modifiable risk factors.